FDA Proposed Rule On PET Drug Manufacturing Expected This Month
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposed current good manufacturing practices requirements for positron emission tomography drugs will reflect the “unique characteristics” of radiopharmaceuticals, HHS says. The rule would build upon a draft guidance and preliminary draft proposed cGMP rule, both issued in 2002.